Pharmaceutical - Genzyme

Filter

Current filters:

Genzyme

Popular Filters

1 to 25 of 54 results

CHMP grants positive opinion to Sanofi/Genzyme's Cerdelga in Gaucher disease

CHMP grants positive opinion to Sanofi/Genzyme's Cerdelga in Gaucher disease

21-11-2014

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued…

CerdelgaEuropeGenzymePharmaceuticalRegulationSanofi

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

Sanofi's third quarter figures are on track but shares fall on diabetes price competition warning

28-10-2014

French drug major Sanofi’s third-quarter earnings are in focus, but the company’s shares have plummeted…

FinancialFranceGenzymePharmaceuticalSanofi

Sanofi posts strong 2nd-qtr earnings, beating estimates

Sanofi posts strong 2nd-qtr earnings, beating estimates

31-07-2014

French pharma major Sanofi this morning reported that group sales for the second quarter of 2014 grew…

FinancialFranceGaucherGenzymeInsulin glargineMajorMiddle EastPharmaceuticalSanofi

AAN 2014: Genzyme’s Lemtrada slows brain atrophy in MS patients

AAN 2014: Genzyme’s Lemtrada slows brain atrophy in MS patients

01-05-2014

French drug major Sanofi and its subsidiary Genzyme presented positive new data from the Lemtrada (alemtuzumab)…

Autoimmune diseasesFranceGenzymeHealthLemtradaMajorMRIMultiple sclerosisNeurologicalPharmaceuticalResearch

UK researchers find pancreatic cancer potential for plerixafor

UK researchers find pancreatic cancer potential for plerixafor

06-01-2014

A possible new method for treating pancreatic cancer which enables the body’s immune system to attack…

GenzymeMozobilOncologyPharmaceuticalPlerixaforResearchSanofi

US FDA calls for more trials on Genzyme’s Lemtrada

US FDA calls for more trials on Genzyme’s Lemtrada

30-12-2013

There was a significant disappointment this morning for French drug major Sanofi, when it revealed that…

BayerGenzymeLemtradaNeurologicalNorth AmericaPharmaceuticalRegulationSanofiUSA

Sanofi’s Aubagio gains backing from UK’s NICE

Sanofi’s Aubagio gains backing from UK’s NICE

08-12-2013

In final draft guidance issued on Friday, the UK drugs watchdog the National Institute for Health and…

AubagioEuropeGenzymeNeurologicalPharmaceuticalPricingRegulationSanofiUK

Sanofi’s Lemtrada gets support from FDA advisory panel

Sanofi’s Lemtrada gets support from FDA advisory panel

14-11-2013

French drug major Sanofi (Euronext: SAN) has received support from a US Food and Drug Administration…

CNS DiseasesEuropeGenzymeLemtradaPharmaceuticalRegulationSanofi

Chronic kidney disease market to witness slight decline by 2017

Chronic kidney disease market to witness slight decline by 2017

12-11-2013

The value of the chronic kidney disease market could drop 2.5% between 2012 and 2017 due to the loss…

EuropeFinancialGenzymeMarkets & MarketingNephrology and HepatologyPharmaceuticalRenagelRenvelaUSAZemplar Capsules

Sanofi says 3rd-qtr profits down, but sees end to patent cliff period

Sanofi says 3rd-qtr profits down, but sees end to patent cliff period

30-10-2013

French drug major Sanofi this morning posted third-quarter 2013 results with a fall in profitability…

FinancialGenzymePharmaceuticalSanofi

Aubagio significantly reduced risk of new clinical relapse or MRI lesion in MS study

03-10-2013

French drug major Sanofi and its subsidiary Genzyme announced positive new data from the TOPIC study…

AubagioGenzymeNeurologicalPharmaceuticalResearchSanofi

UK's NICE calls for more information on MS treatment Aubagio

18-09-2013

UK drugs watchdog the National Institute for Health and Care Excellence (NICE) is calling on Genzyme,…

AubagioBiotechnologyEuropeGenzymeNeurologicalPharmaceuticalPricingRegulationSanofi

Genzyme's MS drug Lemtrada approved in Europe

17-09-2013

French drug major Sanofi (Euronext: SAN) and its USA-based biotech subsidiary Genzyme revealed this morning…

AubagioBiotechnologyEuropeGenzymeLemtradaNeurologicalPharmaceuticalRegulationSanofi

Sanofi's MS drug Aubagio gains final European approval

02-09-2013

Following a positive recommendation from the European Medicines Agency's Committee for Medicinal Products…

AubagioBiotechnologyEuropeGenzymeNeurologicalPharmaceuticalRegulationSanofi

New Zealand to widen access for type 1 and type 3 Gaucher disease drug

07-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC has announced the approval of a proposal to widen…

Asia-PacificBiotechnologyCerezymeGenzymePharmaceuticalRare diseasesRegulationSanofi

Sanofi sees end to "patent cliff" doldrums, as it misses forecasts

01-08-2013

French drug major Sanofi (Euronext: SAN) posted second-quarter 2013 financial results this morning (August…

BiotechnologyFinancialGenzymePharmaceuticalSanofi

Generics take toll on Sanofi's 1st-qtr sales, with net profit down 33.5%

02-05-2013

French drug major Sanofi (Euronext: SAN) today (May 2) reported first-quarter 2013 financial results…

BiotechnologyFinancialGenzymePharmaceuticalSanofi

Sanofi's Aubagio delayed onset of clinically definite MS in TOPIC study

25-04-2013

French drug major Sanofi (Euronext: SAN) US biotech subsidiary Genzyme announced today positive top-line…

AubagioBiotechnologyGenzymeNeurologicalPharmaceuticalResearchSanofi

1 to 25 of 54 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top